Home

Weiterführende Literatur

A
Abouzied MM, Al-sugair A, Meer H et al. (2007) 18F-FDG PET/CT in children: One year experience in a tertiary care setting(Abstr400). J Nucl Med (Suppl2) 48

Agatston A (2007) The South Beach Heart Program(The 4-Step Plan That Can Save Your Life. Rodale Inc :1-289

Anonym (SNM) (2007) Conjoint Statement of the SNM and the ACNP on Credentialing and Delineation od Priviliges for Cardiac PET. J Nucl Med 48:850-51


B
Basu S, Alavi A (2007) Defining co-related parameters between metabolic, flare and clinical, biochemical, and osteoblastic flare and estabilshing guidelines for assessing response to treatment in cancer. Eur J Nucl Med Mol Imaging 34:441-3

Basu S, Houseini M, Mavi A et al. (2007) Correlation of standard uptake value and its change over time in FDG PET imaging with the histopathological characteristics of primary breast malignancy at diagnosis (Abstr.475). J Nucl Med Suppl2, 48:139P

Basu S, Housemi M, Mavi A et al. (2007) Does the primary breast lesion and the metastatic foci behave differently with regard to FDG uptake over time in dual time-point FDG-PET?. J Nucl Med 48:144P

Beheshdi M, Vali R, Langsteger W (2007) 18F- fluorocholine PET/CT in the assessment of bone metastases in prostate cancer (Letter to the E Eur J Nucl Med Mol Imaging 34:1316-17

Breeman WA, Verbruggen AM (2007) The 68Ge/68Ga generator has high potential, but when can we use 68G- labelled tracers in clinical routine ?. JEur J Nucl Med Mol Imaging 34:978-81


C
Czernin J (Guest Editor) (2007) PET/CT in Cancer Patient Management. J Nucl Med, 1S-88S

Czernin J, Allen-Auerbach M, Schelbert HR (2007) Improvements in cancer staging with PET/CT:Literature-based evidence as of September 2006. J Nucl Med Suppl1, 48:78S-88S


D
Di Carli MF, Hachamovitch R (2007) New technology for noninvasive imaging of coronary artery disease. Circulation 115:1464-80

Dresel ST (2007) Wertigkeit der C-11 Cholin PET und PET/CT bei Patienten mit Verdacht auf Prostatakarzinom. Nuklearmedizin/Informationen, BBGN, Berlin 22:1-16


F
Fricke/H.Deckart E (2007) SPECT/CT und PET/CT in der Kardiologie/Nuklearmedizin-Informationenen- BBGNM. Berlin-Buch 22:23-29


G
Gabriel M, Decristoforo C, Kendler D et al. (2007) 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 48:508-18

Gallagher MJ, Ross MA, Raff GL et al. (2007) The diagnostic accuracy of 64 slice computed tomography coronary angiography compared with stress nuclear imaging in emergency department low-risk chest pain patients. Ann Emerg Med 49(2):125-36

Garcia Fifueiras R, Martin CV, Isidro IRE (2007) MRI, CT offer answers to renal mass queries. Diag Imag Europe June/July:9-12

Greenland P, mult. (2007) American College of Cardiology Foundation....(s.14837/4). J Am Coll Cardiol 49(3):378-402

Gregoire V, Hausermans K, Geets X et al. (2007) PET-based treatment planning in radiotherapy:A new standard?. J Nucl Med( Suppl1) 48:68S-77S


H
Hacker M, Jacobs T, Hack N et al. (2007) Combined use of 64-slice computed tomography angiography and gated myocardial perfusion SPECT for te detection of functionally relevant coronary artery stenoses. Nuklearmedizin 46:29-35

Hacker M, Jacobs T, Hack N et al. (2007) Sixty-for slice spiral CT angiography does not predict the functional relevance of coronary artery stenoses in patients with stable angina. Eur J Nucl Med Mol Imaging 34:4-10

Hadi M, Chen CC, Whatley M et al. (2007) Brown fat imaging with 18F-6-fluorodopamine PET/CT, 18F-FDG PET/CT, and 123I-MIBG SPECTA study of patients being evaluated for pheochromcytoma. Eur J Nucl Med Mol Imaging 48:1077-1083

Hartmann A, Eid K, Dora C et al. (2007) Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur J Nucl Med Mol Imaging 34:704-714

Ho Ch, Chen S, Yeung DWC, Cheng THKC (2007) DualTracer PET/CT imaging in evaluation of metastatic hepatocelluar carcinoma. J Nucl Med 48:902-909

Hsu WK, T B, Feely, Krenek L et al. (2007) The use of 18F-fluoride and 18F-FDG PET scans to assess fracture healing in a rat femur model. Eur J Nucl Med Mol Imaging 34:1291-1301


I
Iagaru A, Quon A, Johnson D et al. (2007) 2-Deoxy-2-(F-18)fluoro- D-glucose positron positron emssion tomography /computed tomography in the management of melanoma. Mol Imaging Biol 9:50-57

Ibrahim T, Bolow HP, Hackl T et al. (2007) Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol 49(2):208-216
Israel O, Kuten A (2007) Early detection of cancer recurrence:18-FDG PET/CT can make a difference in diagnosis and patient care. J Nucl Med (Suppl 1) 46:28-35

Ito S, Kato K, Ikeda M et al. (2007) Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer. J Nucl Med 48:889-885


J
Jang S, Kang W, Jang S et al. (2007) Prediction of colon cancer recurrence with CEA level in patient with negative FDG PET (Abstr 483). J Nucl Med (Suppl2) 48:142P


K
Kasamon YL, Jones RJ, Wahl RL (2007) Integrating PET ans PET/CT into the risk-adapted therapy of lymphoma. J Nucl Med , Suppl1, 48:19S-27S

Kim SY, Roh J, Kim M et al. (2007) Use of 18F-FDG for primary treatment strategy in patients with suamous cell carcinoma of the oropharynx. J Nucl Med 48:752-57

Kuehl H, Veit P, Rosenbaum SJ et al. (2007) Can PET/CT replace separate diagnostic CT for cancer imaging ? Optimizing CT protocols for imaging cancers of the chest and abdomen. J Nucl Med (Suppl1) 48:45S-47S


L
Lehman CD, Gatsonis C, Kuhl CHK et al. (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 336:1295-1303

Ligabue G, Rosi R, Faval M et al. (2007) Noninvasive evaluation of coronary artery stents patency after PTCA: role of multi-sclice computed tomography. Radiol Med(Torino) 108(1-2):128-37

Lindner O, Burchert W, Bengel FM et al. (2007) Die Myokardszintigraphie in Deutschland(Ergebnisse der Erhebung 2005 und Standortbestimmung). Nuklearmedizin 46:49-55

Lindner O, Rusche H, Schäfers M et al. (2007) Aktuelle Konzepte der Myokardperfusionsszintigraphie. Dtsch Arztebl 104(14):A952-8

Louis E, Ancion G, Colard A et al. (2007) Noninvasive assessment of Crohn`s disease intestinal lesions with 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 48:1053-59

Lucignani G (2007) Imaging atherosclerosis in the vulnerable patient. Eur J Nucl Med Mol Imaging 34:143-46

Lucignani G (2007) Molecular imaging is indispensable for the development of stem cell-based myocardial regenerative therapy. Eur J Nucl Med Mol Imaging 34:422-25

Lucignani G (2007) The emergence of MRI and MSCT cardiac imaging: nuclear cardiology is not the only actor on stage. Eur J Nucl Med Mol Imaging 34:787-93

M
Mahrholdt H, Klem I, Sechtem U (2007) Cardiovascular MRI for detection myocardial viability and ischemia. Heart 93(1):122-9

Mangili G, Picchio M, Sironi S et al. (2007) Integrated PET/CT as a first-line restaging modality in patients with suspected recurrence of ovarian cancer. Eur J Nucl Med Mol Imaging 34:658-66

Medizinreport (2007) Neues in der Urologie 2005/2006. S dwestdeutsche Gesellschaft fr Urologie e.V. Hess Ärztebl 2:84


N
Nakajima K, Kusuoka H, Nishimura S et al. (2007) Normal limits of ejection fraction and volumes determined by gated SPECT in clinically normal patients without cardiac events: a study based on the J- ACCESS data base. Eur J Nucl Mol Imaging 34:1088-96


P
Pauls S, Buck AK, Hohl K et al. (2007) Inproved non-invasive T-staging in non-small cell lung cancer by integrated 18F- FDG PET/CT. Nuklearmedizin 46:9-14

Ponde DE, Dence CS, Oyama N et al, (2007) 18F-Fluoroacetate:A potential acetate analog for prostate tumor imaging -In vivo evaluation of 18 F-fluoroacetate versus 11 C-acetate. J Nucl Med 48:420-28


R
Riedl CH. C, Akhurst T, Larson ST et al. (2007) 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastaes. J Nucl Med 48:771-775


S
Schepis T, Gemperli O, Koepfli P et al. (2007) Added value of coronary artery calcium score as an adjunct to GATED SPECT for the evaluation of coronary artery disease in an intermediate risk population. J Nucl Med 48:1424-30

Schepis T, Gaemperli O, Koepfli P et al. (2007) Use of coronary calcium score scans from stand-alone multislice computed tomography for attenuation correction of myocardial perfusion SPECT. J Nucl Med Mol Imaging 34:11-19

Scher B, Seitz M, Albinger W et al. (2007) Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging 34:45-53

Schilling J (2007) High-resolution positron emissionmammography in breast cancer. J Nucl Med (Suppl2) 48:139P

Schuijf JD, der Wall EEvan; Bax JJ (2007) Changing paradigm:atherosclerosis versus ischemia. Eur J Nucl Med Mol Imaging 34:1-3

Shen D, Liu D, Cao Z et al. (2007) Coregistration of magnetic resonance and single photon emission computed tomography images for noninvasive localization of stem cells grafted in the infarcted rat myocardium. Mol Imaging Biol 9:42-31

Sironi S, Picchio M, Landoni C et al. (2007) Post-therapy surveillance of patients with uterine cancers:value of integrated PET/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging 34:472-79

Stöckle M, Lehmann J, Krege S et al. (2007) Therapie und Prognose des lymphogen metastasierten Harnblasenkarzinoms. Dtsch Ärztebl 104(14):A959-63


T
Thie JA, Hubner KF, Isidoro FP, Smith GT (2007) A weight index for the standardized uptake value in 2-deoxy-2-(F-18)fluoro-D-glucose positron emission tomography. Mol Imaging Biol 9:91-8


V
Vogel WV, van Riel PLC.M, Oyen WJG (2007) FDG-PET/CT can visualize the extent of inflammation in rheumatoid arthritis of the tarsus (Image of the month). Eur J Nucl Med Mol Imaging 34:439


W
Wang Y, Chiu E, Rosenberg J et al. (2007) Standardized upake value atlas:Characterization of physiological 2-deoxy-2-(18F) fluoro-D-g ucose uptake in normal tissues. Mol Imaging Biol 9:83-90

Watkins S, Oldroyd KG, Frohwein S (2007) Magnetic resonance myocardial perfusion imaging: a new era in the detection of reversible myocardial ischemia. Heart 93(1):7-10

Weber WA, Figlin R (2007) Monitoring cancer treatment with PET/CT:Does it make a difference? J Nucl Med (Suppl1) 48:36S-44S


Y
Yasuda S, Shotsu A, Ide M et al. (2007) Chronic thyreoiditis:diffuse uptake of FDG at PET. Radiology: 775-778


Z
Zoller M, Kohlfuerst S, Igere I, et al. (2007) Combined PET/CT in the follow-up of differentiated thyroid carcinoma: What is the impact of each modality? Eur J Nucl Med Mol Imaging 34:487-495

Zylka-Menhorn V (2007) Rückgang der Brustkrebsinzidenz-Eine Kausalität lässt sich aus den Daten nicht sicher ableiten (Medizinreport zu ANTONIO BREAST CANCER MEETING. Dt Ärztebl 104:C16-17

 

DTZ am Frankfurter Tor
PET/CT • Nuklearmedizin

Kadiner Straße 23
10243 Berlin

Tel.: 030 5596861
Fax: 030 5589524
nuklearmedizin@berlin-dtz.de

Sprechzeiten: Mo-Fr 8:00–18:00 Uhr

Das DTZ ist ein zertifiziertes
Med. Versorgungszentrum (MVZ).